These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11322883)

  • 21. P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach.
    Pleban K; Kopp S; Csaszar E; Peer M; Hrebicek T; Rizzi A; Ecker GF; Chiba P
    Mol Pharmacol; 2005 Feb; 67(2):365-74. PubMed ID: 15509712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
    Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
    Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence.
    Kast C; Canfield V; Levenson R; Gros P
    J Biol Chem; 1996 Apr; 271(16):9240-8. PubMed ID: 8621583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3.
    Kast C; Canfield V; Levenson R; Gros P
    Biochemistry; 1995 Apr; 34(13):4402-11. PubMed ID: 7535563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein.
    Safa AR
    Methods Enzymol; 1998; 292():289-307. PubMed ID: 9711562
    [No Abstract]   [Full Text] [Related]  

  • 26. Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding.
    Dey S; Ramachandra M; Pastan I; Gottesman MM; Ambudkar SV
    Methods Enzymol; 1998; 292():318-28. PubMed ID: 9711564
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.
    Ecker GF; Csaszar E; Kopp S; Plagens B; Holzer W; Ernst W; Chiba P
    Mol Pharmacol; 2002 Mar; 61(3):637-48. PubMed ID: 11854445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of drug interaction sites in P-glycoprotein.
    Greenberger LM
    Methods Enzymol; 1998; 292():307-17. PubMed ID: 9711563
    [No Abstract]   [Full Text] [Related]  

  • 29. Photoaffinity labelling of P-glycoprotein catalytic sites.
    Sankaran B; Bhagat S; Senior AE
    FEBS Lett; 1997 Nov; 417(1):119-22. PubMed ID: 9395088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
    Sharom FJ; Yu X; DiDiodato G; Chu JW
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.
    Safa AR
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):1-17. PubMed ID: 14754408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia.
    Larrivée B; Averill DA
    Biochem Pharmacol; 1999 Jul; 58(2):291-302. PubMed ID: 10423171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photoaffinity labeling of the organic cation/H+ exchanger in renal brush border membrane vesicles.
    Holohan PD; White KE; Sokol PP; Rebbeor J
    J Biol Chem; 1992 Jul; 267(19):13513-9. PubMed ID: 1352295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.
    Liu R; Siemiarczuk A; Sharom FJ
    Biochemistry; 2000 Dec; 39(48):14927-38. PubMed ID: 11101309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection and characterization of verapamil-resistant multidrug resistant cells.
    Cano-Gauci DF; Seibert FS; Safa AR; Riordan JR
    Biochem Biophys Res Commun; 1995 Apr; 209(2):497-505. PubMed ID: 7733917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.
    Chearwae W; Anuchapreeda S; Nandigama K; Ambudkar SV; Limtrakul P
    Biochem Pharmacol; 2004 Nov; 68(10):2043-52. PubMed ID: 15476675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical mechanism of modulation of human P-glycoprotein by stemofoline.
    Chanmahasathien W; Ohnuma S; Ambudkar SV; Limtrakul P
    Planta Med; 2011 Dec; 77(18):1990-5. PubMed ID: 21786221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
    Sauna ZE; Peng XH; Nandigama K; Tekle S; Ambudkar SV
    Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive inhibition of photoaffinity labelling of P-glycoprotein by anticancer drugs and modulators including S9788.
    Demmer A; Dunn T; Hoof T; Kubesch P; Tümmler B
    Eur J Pharmacol; 1996 Nov; 315(3):339-43. PubMed ID: 8982674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.